🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
213.10
+0.40 (0.19%)
Nov 20, 2026, 11:17 AM CET

Zealand Pharma Balance Sheet

Millions DKK. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,2934,577726.03449.311,0691,129
Trading Asset Securities
10,21610,5327,5001,184108.61299.04
Cash & Short-Term Investments
13,50915,1098,2261,6331,1781,428
Cash Growth
-16.45%83.67%403.72%38.65%-17.53%13.56%
Accounts Receivable
3,792174.2187.1797.8115.62153.45
Other Receivables
431145.4797.4440.9921.621.56
Receivables
4,223319.69184.61138.8137.22175.02
Inventory
--10.77.941.29118.44
Prepaid Expenses
237241.62106.39---
Total Current Assets
17,96915,6708,5281,7801,3161,722
Property, Plant & Equipment
245151.43125.25149.85165.49221.45
Long-Term Investments
--819.6321.3837.8426.91
Other Intangible Assets
1,16744.9712.6212.26-53.79
Long-Term Accounts Receivable
---6.8918.1129.09
Long-Term Deferred Tax Assets
10.870.990.932.0213.53
Other Long-Term Assets
5681.4119.418.91-1.27
Total Assets
19,43815,9499,5061,9801,5402,068

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
133256.62181.2891.61180.76266.39
Accrued Expenses
134114.5793.6651.73--
Current Portion of Leases
3422.6316.0416.6614.7314.9
Current Income Taxes Payable
136-----
Current Unearned Revenue
865.34---53.03
Other Current Liabilities
1,267205.8112.5124.59--
Total Current Liabilities
1,712664.97403.47284.58195.49334.32
Long-Term Debt
316302.92285.33-401.35647.91
Long-Term Leases
13480.2190.39102.58108124.63
Long-Term Unearned Revenue
-----14.55
Other Long-Term Liabilities
4070.08109.67-19.0618.43
Total Liabilities
2,2021,118888.86387.15723.91,140

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7271.5271.0258.7551.743.63
Additional Paid-In Capital
14,74514,72914,6816,4064,921-
Retained Earnings
2,3966.29-6,157-4,895-4,172-
Comprehensive Income & Other
2323.3822.3922.714.62884.17
Shareholders' Equity
17,23614,8318,6171,593815.91927.8
Total Liabilities & Equity
19,43815,9499,5061,9801,5402,068

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
484405.77391.76119.23524.08787.43
Net Cash (Debt)
13,02514,7038,6541,514653.77640.72
Net Cash Growth
-17.37%69.90%471.66%131.55%2.04%-43.17%
Net Cash Per Share
184.52205.50130.2626.7514.1514.95
Filing Date Shares Outstanding
66.8470.6170.6558.3851.4743.22
Total Common Shares Outstanding
66.8470.6170.6558.3851.4743.22
Working Capital
16,25715,0058,1241,4951,1211,387
Book Value Per Share
257.88210.04121.9627.2815.8521.47
Tangible Book Value
16,06914,7868,6041,581815.91874.01
Tangible Book Value Per Share
240.42209.41121.7827.0715.8520.22
Machinery
-108.2284.9178.5782.83106.63
Construction In Progress
----0.8712.11
Leasehold Improvements
-41.5239.338.9138.1936.6